“…Also favorably results were recently published, showing that CFR-TTE is a helpful noninvasive tool in the decision making whether to proceed PCI or to continue treatment with medical therapy in patients with intermediate coronary artery stenosis 1,6,7 . On the other hand, in many clinical conditions such as hypertrophic cardiomyopathy (HCM), aortic stenosis, dilatative cardiomyopathy, diabetes, syndrome X and presence of myocardial scar, there is impairment of microcirculation which is reflected with decreased CFR even though coronary arteries are without stenosis 1,[6][7][8][9] . Thus in these patients prediction of significant stenosis is more difficult and there are more often false positive CFR tests.…”